文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球 204 个国家和地区归因于职业性石棉暴露的间皮瘤全球负担:1990-2019 年。

Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.

机构信息

Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

J Cancer Res Clin Oncol. 2024 May 28;150(5):282. doi: 10.1007/s00432-024-05802-6.


DOI:10.1007/s00432-024-05802-6
PMID:38806867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11133219/
Abstract

Malignant mesothelioma, a rare and aggressive cancer primarily caused by occupational asbestos exposure, has a poor prognosis. This study leverages the Global Burden of Disease (GBD) 2019 dataset to analyze the burden of mesothelioma linked to occupational asbestos exposure from 1990 to 2019. The analysis includes the number of mesothelioma deaths and disability-adjusted life years (DALYs) attributable to occupational asbestos exposure, focusing on trends in age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life-year rate (ASDR) by year, age, sex, country, region, and Socio-demographic Index (SDI). In 2019, 91.7% of mesothelioma deaths and 85.2% of DALYs were attributable to occupational asbestos exposure, resulting in 26,820 (95% UI 24,312-28,622) deaths and 569,429 (95% UI 509,956-617,484) DALYs. Despite a decline in ASMR and ASDR from 1990 to 2019, the absolute number of deaths and DALYs almost doubled. The United States reported the highest number of mesothelioma deaths, while China had the highest number of DALYs. Age-specific mortality rates and DALYs decreased in the 25-74 age group but increased in the 75+ age group. In conclusion, occupational asbestos exposure remains the primary cause of mesothelioma worldwide, with an increasing number of deaths and DALYs. The highest incidence rates are observed in high-income areas, and rates are rising in low-income areas. It is crucial to raise awareness about the hazards of asbestos to reduce the global burden of mesothelioma linked to occupational exposure.

摘要

恶性间皮瘤是一种罕见且侵袭性强的癌症,主要由职业性石棉暴露引起,预后较差。本研究利用 2019 年全球疾病负担(GBD)数据集,分析了 1990 年至 2019 年与职业性石棉暴露相关的间皮瘤负担。分析包括归因于职业性石棉暴露的间皮瘤死亡人数和伤残调整生命年(DALY),重点关注按年龄标准化死亡率(ASMR)和按年龄标准化伤残调整生命年率(ASDR)的趋势,按年份、年龄、性别、国家、地区和社会人口指数(SDI)进行分层。2019 年,91.7%的间皮瘤死亡和 85.2%的 DALY 归因于职业性石棉暴露,导致 26820 例(95%UI 24312-28622)死亡和 569429 例(95%UI 509956-617484)DALY。尽管 1990 年至 2019 年 ASMR 和 ASDR 有所下降,但死亡人数和 DALY 的绝对值几乎翻了一番。美国报告的间皮瘤死亡人数最多,而中国的 DALY 人数最多。特定年龄组的死亡率和 DALY 在 25-74 岁年龄组下降,但在 75 岁以上年龄组上升。总之,职业性石棉暴露仍然是全球间皮瘤的主要原因,死亡人数和 DALY 呈上升趋势。高收入地区的发病率最高,低收入地区的发病率呈上升趋势。提高对石棉危害的认识对于减轻与职业暴露相关的全球间皮瘤负担至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/6f504d62cd43/432_2024_5802_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/f0b514159d7a/432_2024_5802_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/e25390779f91/432_2024_5802_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/098a6e8c7286/432_2024_5802_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/4f3d265eb686/432_2024_5802_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/6f504d62cd43/432_2024_5802_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/f0b514159d7a/432_2024_5802_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/e25390779f91/432_2024_5802_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/098a6e8c7286/432_2024_5802_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/4f3d265eb686/432_2024_5802_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2004/11793498/6f504d62cd43/432_2024_5802_Fig5_HTML.jpg

相似文献

[1]
Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.

J Cancer Res Clin Oncol. 2024-5-28

[2]
Global, regional and country-specific burden of larynx cancer due to occupational exposure to asbestos: a systematic analysis of the Global Burden of Disease Study 2021.

BMC Public Health. 2025-7-2

[3]
Deaths burden of laryngeal cancer attributable to occupational exposure in the male working age population: findings from global burden of disease study 2021.

Front Public Health. 2025-6-27

[4]
The global burden of aortic aneurysm attributable to hypertension from 1990 to 2021: Current trends and projections for 2050.

PLoS One. 2025-7-18

[5]
Burden of knee osteoarthritis in China and globally: 1990-2045.

BMC Musculoskelet Disord. 2025-7-1

[6]
The global burden of stroke attributable to high alcohol use from 1990 to 2021: An analysis for the global burden of disease study 2021.

PLoS One. 2025-7-14

[7]
[Analysis of the potential disease burden of occupational polycyclic aromatic hydrocarbons exposure-associated lung cancer in China from 1990 to 2021].

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2025-6-20

[8]
Global, regional, and national burden of thyroid cancer in women of child-bearing age, 1990 to 2021 and predictions to 2035: An analysis of the global burden of disease study 2021.

Front Endocrinol (Lausanne). 2025-6-27

[9]
Ambient versus household PM exposure and socioeconomic disparities in intracerebral hemorrhage burden: a 32-year global analysis (1990-2021) with projections to 2050.

Front Public Health. 2025-6-18

[10]
Global pattern, trend and cross-country inequalities of inguinal, femoral, and abdominal hernia among individuals aged 60 and above from 1990 to 2021 and projections until 2040: a population-based study.

Surg Endosc. 2025-5-28

引用本文的文献

[1]
Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021.

PLoS One. 2025-8-21

[2]
Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021.

BMC Cancer. 2025-7-16

[3]
Global, regional and country-specific burden of larynx cancer due to occupational exposure to asbestos: a systematic analysis of the Global Burden of Disease Study 2021.

BMC Public Health. 2025-7-2

[4]
HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy.

Toxics. 2025-5-28

[5]
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma.

Cancer Sci. 2025-9

[6]
Mesothelioma Incidence Rates in Australia since 1982: Exploring Age, Period, and Cohort Effects and Future Projections.

Cancer Epidemiol Biomarkers Prev. 2025-7-1

[7]
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets.

Cancers (Basel). 2025-3-30

[8]
Burden of mesothelioma in the Middle East and North Africa: a 32-year analysis of the Global Burden of Diseases Study 2021.

Ann Med Surg (Lond). 2025-2-28

[9]
Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report.

Am J Case Rep. 2025-4-6

本文引用的文献

[1]
Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990-2019 and prediction to 2035: worsening or improving?

BMC Public Health. 2024-3-18

[2]
Asbestos Exposure and Ovarian Cancer: A Meta-analysis.

Saf Health Work. 2024-3

[3]
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.

Mol Oncol. 2024-4

[4]
Recycling thermally deactivated asbestos cement in mortar: A possible route towards a rapid conclusion of the "asbestos problem".

J Environ Manage. 2024-3

[5]
Classification of asbestos and their nonasbestiform analogues using FTIR and multivariate data analysis.

J Hazard Mater. 2024-5-5

[6]
The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis.

Pulmonology. 2025-12-31

[7]
Assessment of asbestos-cement roof distribution and prioritized intervention approaches through hyperspectral imaging.

Heliyon. 2024-2-6

[8]
Asbestos and disease - a public health success story?

Scand J Work Environ Health. 2024-3-1

[9]
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.

Front Immunol. 2023

[10]
Comprehensive clinical overview of malignant pleural mesothelioma.

Respir Med. 2024-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索